Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $57.33 and traded as low as $57.05. Utah Medical Products shares last traded at $57.59, with a volume of 15,951 shares changing hands.
Utah Medical Products Stock Performance
The stock has a market capitalization of $183.40 million, a price-to-earnings ratio of 14.93 and a beta of 0.28. The company has a fifty day simple moving average of $55.38 and a two-hundred day simple moving average of $57.27.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 EPS for the quarter. Utah Medical Products had a return on equity of 10.74% and a net margin of 33.00%. The company had revenue of $9.71 million during the quarter.
Utah Medical Products Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, July 3rd. Shareholders of record on Monday, June 16th were given a $0.305 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.16%. Utah Medical Products's dividend payout ratio (DPR) is presently 32.28%.
Institutional Investors Weigh In On Utah Medical Products
A number of institutional investors have recently made changes to their positions in UTMD. Tower Research Capital LLC TRC lifted its stake in shares of Utah Medical Products by 172.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock valued at $32,000 after purchasing an additional 328 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Utah Medical Products by 24.9% in the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after purchasing an additional 384 shares during the period. Bessemer Group Inc. acquired a new position in shares of Utah Medical Products in the 4th quarter valued at about $31,000. Golden State Wealth Management LLC lifted its stake in shares of Utah Medical Products by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock valued at $56,000 after purchasing an additional 500 shares during the period. Finally, PNC Financial Services Group Inc. lifted its stake in shares of Utah Medical Products by 156.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock valued at $50,000 after purchasing an additional 546 shares during the period. Institutional investors own 69.60% of the company's stock.
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Recommended Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
